Latest Regulatory Approval News

Mamba Exploration has identified over 20km of gold mineralisation strike at its Meeka East Gold Project, extending the Mulga Bill trend and unveiling new anomalies. The company secured up to $90,000 in co-funding from the WA Government’s Exploration Incentive Scheme to advance drilling plans.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.

Finder Energy has completed the first tranche of its $33 million capital raise, issuing 42 million shares at 50 cents each to institutional and professional investors. The company will seek shareholder approval in June for a second tranche involving 12 million more shares.

Hartshead Resources has sent its Scheme Booklet to shareholders detailing ACAM GP Limited's proposed $40 million acquisition at a significant premium. The Board unanimously backs the all-cash offer, with a shareholder meeting set for 8 June 2026.

Amaero Ltd is set to re-domicile from Australia to Delaware via court-approved schemes, issuing US HoldCo CHESS Depositary Interests to shareholders while maintaining its ASX listing. The move aims to tap into deeper US capital markets and enhance strategic growth opportunities.

Bremworth Limited and Floorscape Limited have pushed back the deadline for their acquisition scheme to 7 August 2026 after the New Zealand Commerce Commission extended its decision date to 29 May. The deal remains contingent on regulatory approval and shareholder consent.

Amplitude Energy has received the VIC/L37 production licence for its Annie gas field, setting the stage for first gas in 2028 to supply Australia's east coast market.

Aland Equity Group (ASX: AEG) reveals advanced talks on a property funds management transaction linked to its chairman, explaining recent unusual share price activity.

Hawk Resources has clinched a Mineral Exploration Agreement with Ngaanyatjarrra Traditional Owners for its Olympus Scandium Project, clearing a key hurdle ahead of planned Q2 2026 exploration. Historical data points to a significant scandium anomaly that could define a new province in Western Australia.

BPH Global inks binding deal with Temasek Innovation Holdings to validate its seaweed-based male vitality product through targeted biological assays, advancing regulatory and commercial ambitions.

PYC Therapeutics has dosed the first patient in its Phase 1b trial of PYC-003, targeting Polycystic Kidney Disease, aiming to establish safety and efficacy markers ahead of registrational studies.

Superloop showcased sustained earnings improvement and strategic fibre network expansion, spotlighting its pending Lightning Broadband acquisition to boost FTTP scale.